Aspire Biopharma Hldgs Q4 EPS $(1.84) Down From $(1.10) YoY, Sales $4.261K Up From $0 YoY

Aspire Biopharma Hldgs (NASDAQ:ASBP) reported quarterly losses of $(1.84) per share. This is a 67.27 percent decrease over losses of $(1.10) per share from the same period last year. The company reported $4.261 thousand in sales this quarter. This is a 426.00K percent increase over sales of $1.000 the same period last year.